65,437 trials
Diphtheria · Polio · Pertussis
Primary: Percentage of Participant Responding to Pertussis Antigens Post-Dose 3 of Pentacel® or DAPTACEL®, IPOL®, and ActHIB® Vaccinations. — 98; 99; 99; 99 Percentage of…
Bacterial Infections
Primary: Clinical Cure Rate at Test of Cure (TOC) (MITT Population) — 304; 297; 29; 21 participants
Bacterial Pneumonia
Primary: Clinical Cure Rate for Ceftaroline Compared to That for Ceftriaxone at the Test of Cure (TOC) in the Modified Intent to Treat Efficacy (MITTE) Population — 235; 206; 47…
Breast Cancer · Metastasis
Primary: Number of Participants With Objective Response — 0; 1; 1; 1 participants
Dyslipidemia
Primary: Percentage of Participants Who Were Compliant With Statin Treatment — 86.7 Percentage of participants
Renal Cell Carcinoma
Primary: Number of Participants With Categorical Best Overall Response — 13; 130; 120; 58 Participants
Smokeless Tobacco Use
Primary: Number of Participants With Tobacco Abstinence — 14; 11 participants — p=.432
Chronic Hepatitis C (HCV)
Primary: Number of Subjects With Any Adverse Event (Side Effect) and the Severity of Those Adverse Events — 5; 2; 3; 3 participants
Migraine Disorders
Primary: Mean Change From Baseline in Systolic and Diastolic Blood Pressure at Month 6 for Sumatriptan/Naproxen — 111.7; 107.1; -2.9; 76.0 millimeters of mercury (mmHg)
Total Laryngectomy
Primary: Short-term Feasibility Provox Vega 22.5 French — 15 Patients
Total Laryngectomy
Primary: Patient Preference — 14; 7; 11 Patients
Leukemia, Lymphocytic, Acute
Primary: Toxicity of Treatment in Terms of Number of Participants With Serious Adverse Events or Adverse Events, Reported — 26 Participants
TOBACCO USE CESSATION
Primary: Biochemically Verified 7-day Point Prevalence Abstinence — 89; 58 Participants
Diabetes
Primary: Percent of Blood Glucose (BG) Results Within +/-15mg/dL or +/-20% of Laboratory Glucose Method — 97.1; 97.9 percent of blood glucose results
Psoriasis
Primary: Number of Subjects With Physician's Global Assessment of Psoriasis (PGA) of Clear or Almost Clear at Week 16 — 1; 15 subjects — p=0.014